AWARDDCASmall business
Dca HHSN271201200032CKDH RESEARCH AND COMMUNICATION, INC
Overview
Award facts
- Period of performance
- Jun 2, 2015 to Dec 31, 2014
- Ended
- Modifications
- 4
- Latest action Jun 2, 2015
- Contract type
- Dca
- PIID HHSN271201200032C
Description of requirement
IGF::OT::IGF OTHER FUNCTIONS: SECURX: PREVENTING PRESCRIPTION DRUG DIVERSION. N44DA-12-5572, TO KDH RESEARCH AND COMMUNICATIONS, INC. BASE AWARD. 09/24/2012-09/23/2014.
Dates and value
- Award date
- Signed on Sep 19, 2012
- Potential end of performance
- Dec 30, 2014
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jun 2, 2015. View on USAspending · Recipient on SAM.gov
Recipient
LocationATLANTA, GA
UEINWLEP7EH4JN7
Business sizeSmall businessSize at award, per the contracting officer
Parent companyKDH RESEARCH AND COMMUNICATION, INC
Business types and certifications
Women-ownedFor-profit organizationSubchapter S corporationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NIH, NIDA, OD OM OA OFC ACQUISITIONS
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NIH, NIDA, OD OM OA OFC ACQUISITIONS
Place of performance
- Place of performance
- Atlanta, Fulton County, Georgia 30308-1212 United States Of America
- Congressional district (place of performance)
- GA-05As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN11R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH) (research and development)
Competition
- Extent competed
- Not available for competitionB
- Reason not competed
- Authorized by statuteOTH
- Solicitation procedures
- Only one sourceSSS
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 1
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- Securx: preventing prescription drug diversion
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Service Contract Act labor standards
- No
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not a bundled requirementD
- Consolidated requirement
- No
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Sep 19, 2012Base obligation at award: $749,970
- Latest action
- Jun 2, 2015 — CloseoutModification 4; administrative: no change in scope or value
- Actions by type
- Base award1
- Other administrative action3
- Closeout1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Synopsized publicly (SAM.gov / FedBizOpps)
- No
- Simplified procedures for commercial items
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Walsh-Healey Act (materials and supplies)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- DcaD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 00271
- Transactions recorded under this award key
- 5
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 00271